ʻO ka hoʻomohala ʻana o ka ʻoihana lāʻau lapaʻau honua i ka makahiki 2023 aia nō i kahi manawa haʻalulu, aʻo nā ʻoihana lapaʻau kūloko a me nā ʻāina ʻē e uku nui aku i ka hoʻopukapuka R&D.I nā makahiki he ʻumi e hiki mai ana, hiki i ka ʻoihana lāʻau lapaʻau ke alo i nā loli nui, ʻo ka hoʻololi nui loa ʻo ia ka ʻōnaehana kulekele honua.I loko o ke kaiapuni o ka hoʻololi nui, loaʻa i nā hui lāʻau lapaʻau nā ʻano ʻano like ʻole e hana ai me ia, e like me ka hoʻomaʻamaʻa huahana, lālā kūʻai aku, nā hana hoʻohālike a pēlā aku.
Ke kū nei nā ʻoihana lāʻau lapaʻau i nā pilikia nui aʻe i luna.I kēia manawa, ʻoi aku ka nānā ʻana o nā hui lāʻau lapaʻau i ka hoʻopukapuka R&D a hoʻonui i nā waihona kālā. Hōʻike ka noiʻi ua hoʻolilo kekahi mau ʻoihana kaulana i ka nui o 3.6 biliona i ka noiʻi a me ka hoʻomohala ʻana, a ua hoʻolilo ʻo CanSino's COVID-19 ma mua o 1.014 biliona. Hoʻokomo kālā R&D.A ua hoʻopuka ka mea hoʻopale TIGIT o BeiGene i $2.9 biliona, ua hoʻolilo ʻo Rongchang Bio's Vidicumumab i $2.6 biliona.I ka manawa like, i nā makahiki i hala iho nei, me ka hoʻololi ʻana o nā maʻi kanaka, aia nā lāʻau lapaʻau ola i ka piʻi ʻana o nā pono, a nui nā hui e kau nei i ke ala o ka R&D biological dru.g.
Ua paʻa ʻo Hunan Honya Biotec Co., Ltd. i ka hana ʻana i nā lako hana synthesis DNA kiʻekiʻe a me nā ʻōnaehana synthesis i hoʻohui ʻia no nā makahiki he 10.ʻO ka noiʻi kūʻokoʻa a me ka hoʻolālā hoʻomohala ʻana, he hui nona ka iwi kuamoʻo o ʻoi aku ma mua o 20 mau loea biology a me nā ʻenekini i puka i ke kula ʻo Tsinghua.Hiki iā mākou ke hāʻawi i nā kumu waiwai maka kiʻekiʻe no nā kahua noiʻi ʻepekema ola e like me ka noiʻi gene, molecular diagnostic, nucleic acid drug development, etc. Ma ka manawa like, he hoa nui mākou o nā hui lāʻau lapaʻau, e kōkua ana iā lākou e wikiwiki i ka R&D a hoʻomaikaʻi. pono.E hana pū e kōkua i ka hoʻomohala ʻana a me ka holomua o ka ʻoihana biomedical i kahi kenekulia hou.
.
Ka manawa hoʻouna: Apr-18-2023